GlassScriptPhysician profile
Taseer A Minhas
NPI 1508941972
$16,150.77
in general payments reported to CMS, 2019-2025
67 companies · $2,388 in 2025
The $2,388 reported for 2025 was more than what 75% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,651 · 2020: $1,762 · 2021: $3,280 · 2022: $2,014 · 2023: $2,444 · 2024: $2,611 · 2025: $2,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,431 · Education: $12.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,430.90 |
| Education | $12.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,211.21 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $828.78 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $779.51 | 2019-2025 | Austedo Xr, Austedo, Ajovy |
| Emd Serono, INC. | $750.63 | 2019-2025 | Mavenclad |
| Ucb, INC. | $572.74 | 2019-2025 | Rystiggo, Briviact, Nayzilam |
| Allergan, INC. | $482.99 | 2019-2022 | |
| Biogen, INC. | $412.20 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Sk Life Science, INC. | $391.83 | 2020-2025 | |
| Mdd US Operations, LLC | $385.16 | 2019-2024 | Gocovri, Myobloc, Apokyn |
| Genzyme Corporation | $334.79 | 2019-2025 | |
| Livanova USA, INC. | $300.56 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Lundbeck LLC | $299.30 | 2019-2025 | Vyepti |
| Pfizer INC. | $295.11 | 2021-2025 | |
| Supernus Pharmaceuticals, INC. | $283.62 | 2019-2025 | Qelbree |
| Amgen INC. | $259.97 | 2019-2024 | Aimovig |
Show all 67 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taseer Minhas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.